Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

83,427 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Independence Blue Cross	Enzyme Replacement Therapy for Mucopolysaccharidosis (e.g., Aldurazyme, Elaprase, Vimizim, Naglazyme, Mepsevii, etc.)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-034	New policy
Aug 2, 2026	Independence Blue Cross	Enzyme Replacement for the Treatment of Gaucher's DiseasePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-023	New policy
Aug 2, 2026	Independence Blue Cross	Enteral Nutritional TherapyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-003	New policy
Aug 2, 2026	Independence Blue Cross	Enfortumab vedotin-ejfv (Padcev)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-113	New policy
Aug 2, 2026	Independence Blue Cross	Endovascular Stent Graft Repair of Thoracic Aortic Aneurysms and Nonaneurysmal LesionsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-062	New policy
Aug 2, 2026	Independence Blue Cross	Endovascular Grafts for Abdominal Aortic Aneurysms (AAA), Aorto-Iliac Aneurysms, and Infrarenal Aortic AneurysmsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-012	New policy
Aug 2, 2026	Independence Blue Cross	Endoscopic Submucosal Dissection (ESD)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-118	New policy
Aug 2, 2026	Independence Blue Cross	Endometrial AblationPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-065	New policy
Aug 2, 2026	Independence Blue Cross	Emapalumab-lzsg (Gamifant)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-104	New policy
Aug 2, 2026	Independence Blue Cross	Elranatamab-bcmm (Elrexfio)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-168	New policy
Aug 2, 2026	Independence Blue Cross	Electromyography (EMG) Studies, Nerve Conduction Studies (NCS), and Related Electrodiagnostic StudiesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-050	New policy
Aug 2, 2026	Independence Blue Cross	Electroconvulsive Therapy (ECT)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA14-001	New policy
Aug 2, 2026	Independence Blue Cross	Efgartigimod alfa-fcab (Vyvgart) and efgartigimod-alfa and hyaluronidase-qvfc (Vyvgart Hytrulo)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-142	New policy
Aug 2, 2026	Independence Blue Cross	Efbemalenograstim alfa-vuxw (Ryzneuta), Eflapegrastim-xnst (Rolvedon), Pegfilgrastim (Neulasta) and Related BiosimilarsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-082	New policy
Aug 2, 2026	Independence Blue Cross	Eculizumab (Soliris) and Related Biosimilars, Ravulizumab-cwvz (Ultomiris) for intravenous  administrationPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-044	New policy
Aug 2, 2026	Independence Blue Cross	Durvalumab (Imfinzi) and Tremelimumab-actl (Imjudo)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-123	New policy
Aug 2, 2026	Independence Blue Cross	Durable Medical Equipment (DME) Not Subject to a Rental to Purchase MaximumPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-028	New policy
Aug 2, 2026	Independence Blue Cross	Durable Medical Equipment (DME)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-044	New policy
Aug 2, 2026	Independence Blue Cross	Drug-Eluting Beads and Bland Embolization for the Treatment of Hepatic MalignanciesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-041	New policy
Aug 2, 2026	Independence Blue Cross	Dostarlimab-gxly (Jemperli)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-136	New policy
Aug 2, 2026	Independence Blue Cross	Dofetilide (Tikosyn) Use in the Inpatient SettingPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-021	New policy
Aug 2, 2026	Independence Blue Cross	Direct Endoscopic Necrosectomy (DEN) for the Treatment of Pancreatic NecrosisPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-115	New policy
Aug 2, 2026	Independence Blue Cross	Direct Access to Obstetrics/Gynecology (OB/GYN) ServicesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-032	New policy
Aug 2, 2026	Independence Blue Cross	Dermabrasion for Rhinophyma, Septoplasty, Rhinoplasty, and SeptorhinoplastyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-099	New policy
Aug 2, 2026	Independence Blue Cross	Denosumab (Prolia, Xgeva) and related biosimilars, and Romosozumab-aqqg (Evenity)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-052	New policy
Aug 2, 2026	Independence Blue Cross	Deep Brain Stimulation (DBS)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-005	New policy
Aug 2, 2026	Independence Blue Cross	Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe NailsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-014	New policy
Aug 2, 2026	Independence Blue Cross	Day RehabilitationPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA10-005	New policy
Aug 2, 2026	Independence Blue Cross	Datopotamab deruxtecan (Datroway)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-185	New policy
Aug 2, 2026	Independence Blue Cross	Daratumumab (Darzalex), Daratumumab and Hyaluronidase-fihj (Darzalex Faspro)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-079	New policy
Aug 2, 2026	Independence Blue Cross	Cryosurgical Ablation of the Prostate GlandPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-022	New policy
Aug 2, 2026	Independence Blue Cross	Crovalimab-akkz (PiaSky)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-178	New policy
Aug 2, 2026	Independence Blue Cross	Crizanlizumab-tmca (Adakveo)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-109	New policy
Aug 2, 2026	Independence Blue Cross	Cranial Electrotherapy StimulationPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-066	New policy
Aug 2, 2026	Independence Blue Cross	Coverage of Medical DevicesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-040	New policy
Aug 2, 2026	Independence Blue Cross	Cosmetic ProceduresPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA12-009	New policy
Aug 2, 2026	Independence Blue Cross	Cosibelimab-ipdl (Unloxcyt)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-184	New policy
Aug 2, 2026	Independence Blue Cross	Corneal Pachymetry Using UltrasoundPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-046	New policy
Aug 2, 2026	Independence Blue Cross	Contrast Agents Used in Conjunction with EchocardiographyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA09-004	New policy
Aug 2, 2026	Independence Blue Cross	Continuous Glucose Monitors and Home Blood Glucose Monitors and SuppliesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-002	New policy
Aug 2, 2026	Independence Blue Cross	Computer-Assisted Musculoskeletal Surgical Navigational Orthopedic ProcedurePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-088	New policy
Aug 2, 2026	Independence Blue Cross	Computer-Aided Detection (CAD) System for Use with Chest RadiographsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA09-014	New policy
Aug 2, 2026	Independence Blue Cross	Compression GarmentsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-045	New policy
Aug 2, 2026	Independence Blue Cross	Composite Tissue Allotransplantation of the Hand(s) and FacePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-112	New policy
Aug 2, 2026	Independence Blue Cross	Complementary and Integrative Health ServicesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA12-001	New policy
Aug 2, 2026	Independence Blue Cross	Commode ChairsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-036	New policy
Aug 2, 2026	Independence Blue Cross	Collagenase clostridium histolyticum ( Xiaflex ), collagenase clostridium histolyticum-aaes (Qwo)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-128	New policy
Aug 2, 2026	Independence Blue Cross	Cochlear ImplantationPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-039	New policy
Aug 2, 2026	Independence Blue Cross	Cobalamin (Vitamin B12), Folic Acid, and Homocysteine TestingPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA06-032	New policy
Aug 2, 2026	Independence Blue Cross	Coagulation FactorsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-004	New policy